Dimensional Fund Advisors LP Alnylam Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 305,563 shares of ALNY stock, worth $141 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

305,563

Previous 309,819 1.37%

Holding current value

$141 Million

Previous $83.7 Million 19.11%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$224.32 - $326.09 $954,705 - $1.39 Million	-4,256 Reduced 1.37%	305,563 $99.6 Million
Q1 2025 May 13, 2025	SELL	$233.07 - $290.7 $5.56 Million - $6.93 Million	-23,842 Reduced 7.15%	309,819 $83.7 Million
Q4 2024 Feb 13, 2025	BUY	$232.27 - $300.43 $7.5 Million - $9.7 Million	32,272 Added 10.71%	333,661 $78.5 Million
Q3 2024 Nov 07, 2024	BUY	$233.81 - $287.01 $8.23 Million - $10.1 Million	35,183 Added 13.22%	301,389 $82.9 Million
Q2 2024 Aug 09, 2024	BUY	$143.31 - $247.0 $1.58 Million - $2.72 Million	11,027 Added 4.32%	266,206 $64.7 Million
Q1 2024 May 10, 2024	SELL	$146.51 - $198.2 $1.74 Million - $2.35 Million	-11,855 Reduced 4.44%	255,179 $38.1 Million
Q4 2023 Feb 07, 2024	BUY	$151.41 - $196.57 $2.29 Million - $2.97 Million	15,123 Added 6.0%	267,034 $51.1 Million
Q3 2023 Nov 09, 2023	BUY	$170.77 - $211.65 $1.86 Million - $2.31 Million	10,921 Added 4.53%	251,911 $44.6 Million
Q2 2023 Aug 09, 2023	BUY	$185.01 - $212.05 $4.16 Million - $4.77 Million	22,511 Added 10.3%	240,990 $45.8 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $4.37 Million - $5.63 Million	23,903 Added 12.28%	218,479 $43.8 Million
Q4 2022 Feb 09, 2023	BUY	$185.53 - $241.31 $3.4 Million - $4.42 Million	18,310 Added 10.39%	194,576 $46.2 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $393,592 - $659,112	2,841 Added 1.64%	176,266 $35.3 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $944,815 - $1.33 Million	-7,846 Reduced 4.33%	173,425 $25.3 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $268,476 - $367,124	2,111 Added 1.18%	181,271 $29.6 Million
Q4 2021 Feb 09, 2022	SELL	$159.56 - $209.29 $1.29 Million - $1.7 Million	-8,103 Reduced 4.33%	179,160 $30.4 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $3.01 Million - $3.68 Million	-17,736 Reduced 8.65%	187,263 $35.4 Million
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $2.92 Million - $4.02 Million	-22,703 Reduced 9.97%	204,999 $34.7 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $925,732 - $1.28 Million	-7,299 Reduced 3.11%	227,702 $32.2 Million
Q4 2020 Feb 25, 2021	BUY	$122.97 - $147.0 $28.9 Million - $34.5 Million	235,001 New	235,001 $30.5 Million

Others Institutions Holding ALNY

# of Institutions

751

Shares Held

115M

Call Options Held

584K

Put Options Held

672K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $56.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Alnylam Pharmaceuticals, Inc. Transaction History